ICTA and its Themis experts network have made their 30 year-long experience in clinical R&D available to the design of new adaptive studies with real-life realizations on the field. Whereas adaptive methodologies are the focus of all, actually the whole of the clinical development is being renewed, exploratory or confirmatory phases, without leaving aside the post-authorisation step which will undergo a near revolution with namely the "Health Technology Assessment" and the pharmacoepidemiological studies.
The 3 chronicles made available to you by ICTA are the reflection of an irreversible evolution of clinical R&D. We have tried to tackle these topics in the most attractive way. We wish you a warm welcome within the world of these new chronicles, hoping that you will find them of interest.
Do not hesitate to contact us for more details.
